Axial-centrifugal flow catheter pump for cavopulmonary assistance

Information

  • Patent Grant
  • 8777832
  • Patent Number
    8,777,832
  • Date Filed
    Thursday, March 14, 2013
    11 years ago
  • Date Issued
    Tuesday, July 15, 2014
    10 years ago
Abstract
An axial-centrifugal flow catheter pump for cavopulmonary assistance is provided, incorporating a rotor providing both an axial fluid flow and a centrifugal fluid flow. The rotor includes a first terminal impeller configured to provide a centrifugal and axial fluid flow in a first direction, a second terminal impeller configured to provide a centrifugal and axial fluid flow in a second direction opposite to the first direction, and a central impeller configured to provide a predominantly centrifugal fluid flow. The first and second terminal impellers each include blade arrangements configured to provide a centrifugal and axial fluid flow directed toward the rotor central impeller. Cavopulmonary assistance devices are provided including the axial-centrifugal flow catheter pump.
Description
TECHNICAL FIELD

The present invention relates generally to the field of medical devices. In particular, the invention relates to cardiac medical devices and systems for use in remediating or alleviating failing circulation subsequent to a Fontan procedure.


BACKGROUND OF THE INVENTION

The Fontan or Fontan/Kreutzer procedure is a palliative (not curative) surgical procedure used to ameliorate complex congenital heart defects, especially in the young. Exemplary heart defects addressed by the Fontan procedure include heart valve defects (tricuspid atresia, pulmonary atresia), abnormalities in pumping ability of the heart (hypoplastic left heart syndrome, hypoplastic right heart syndrome), and other complex congenital heart diseases where a bi-ventricular repair is not possible or contra-indicated (double inlet left ventricle, hetertaxy defects, double outlet right ventricle, etc.). The process was initially described as a surgical treatment for tricuspid atresia.


As a result of the Fontan procedure, a surgically created junction is provided between the superior and inferior vena cava and the pulmonary artery, and venous blood flow is diverted from the superior and inferior vena cava directly to the pulmonary artery, bypassing the right ventricle of the heart. Following the procedure, oxygen-poor blood from the upper and lower body flows through the lungs without being pumped by the heart. Rather, the blood flow into the lungs is driven only by central venous blood pressure. This corrects hypoxia, and leaves a single heart ventricle responsible only for supplying blood to the body.


However, disadvantages and post-surgical complications are associated with the Fontan procedure. In the short term, pleural effusions (fluid build-up around the lungs) can occur, requiring additional surgical interventions. In the long term, atrial scarring may be associated with atrial flutter and atrial fibrillation, also requiring additional surgical intervention. Other long-term risks may be associated with the procedure, such as protein-losing enteropathy and chronic renal insufficiency, although these latter risks are not yet fully quantified.


Also, a high central venous pressure is required to provide a satisfactory supply of blood to the lungs after the Fontan procedure. Immediately or even 2-5 years following the procedure, it is known that the surgically created Fontan circulation often fails due to that high venous pressure required to drive pulmonary circulation. Long term mortality following the Fontan procedure can be as high as 29.1%, characterized by catastrophic failure of circulation and death. The expected event-free survival rate following the Fontan procedure at one, ten, and twenty-five years following the procedure is 80.1%, 74.8%, and 53.6%, respectively. A bi-modal age distribution has been observed in failing Fontan circulation. In early post-operative cases of failing Fontan circulation, the Fontan connection must be surgically taken down. In later post-operative cases, often the only remedy is heart transplantation.


Because of the above complications, in cases of failing Fontan circulation cavopulmonary assistance is often indicated, to actively move blood from the superior/inferior vena cava into pulmonary circulation, to decrease the central venous pressure required to provide the needed flow of blood to the lungs, and to reverse the pathophysiology associated with failing Fontan circulation. Attempts have been made to alleviate failing Fontan circulation by implanting a right ventricular assist device (RVAD). However, this requires a traumatic surgical intervention to implate the device, and also requires take-down of the Fontan connection to allow pump installation. Dual hemopumps have been evaluated to restore or assist failing Fontan circulation. However, in such cases using two hemopumps, two surgical site cannulations are required, which is unduly traumatic to a patient. Also, patient mobility is severely restricted when two pumps must be deployed by cannulation.


A number of smaller pumps have been evaluated, but most require two pumping mechanisms for deployment in the superior and inferior vena cava (above and below the surgically created Fontan connection) to move blood toward and into pulmonary circulation. Because of the dual pumps/dual cannulations required, such pumps cannot be made ambulatory, i.e. the patient must be substantially bedridden after deployment of the pumps. Single pump mechanisms have been evaluated. Such pumps can create the required flow of blood into the pulmonary artery, but are difficult to deploy and consistently maintain in position due to the need for precise placement at the Fontan anastomosis surgically created at the juncture of the superior/inferior vena cava and the pulmonary artery. Proper alignment of this type of pump at the pulmonary artery and retaining that proper alignment is difficult to impossible, even with patient sedation, and further because of the difficulting in maintaining proper positioning after deployment, such pumps cannot be made ambulatory. Still other single pump mechanisms considered require surgical creation of an offset between the superior and inferior vena cava to promote blood flow into the pulmonary artery, increasing surgical difficulty and resultant complications for the patient.


There is accordingly a need in the art for improvements to pumps for cavopulmonary assistance in the event of failing Fontan circulation. Such improved pumps should require only a single pump mechanism requiring only one cannulation, but should still create satisfactory blood flow from both the superior and inferior vena cava into the pulmonary artery. Moreover, the pump should be relatively simple to deploy at the surgically created Fontan connection site, should not require absolutely precise placement to provide proper pump operation and blood flow, and should allow for a degree of displacement after deployment without affecting proper pump operation and blood flow. Still more, the pump should be ambulatory, allowing patient mobility and improved comfort after the procedure.


SUMMARY OF THE INVENTION

In accordance with the above-identified need in the art, in one aspect the present disclosure provides an axial-centrifugal flow catheter pump for cavopulmonary assistance, including a rotor having elements providing both an axial fluid flow and a centrifugal fluid flow and a motor operatively connected to the rotor. The rotor includes a first terminal impeller configured to provide a centrifugal and axial fluid flow in a first direction, a second terminal impeller configured to provide a centrifugal and axial fluid flow in a second direction opposite to the first direction, and a central impeller configured to provide a predominantly centrifugal fluid flow. To provide the desired fluid flow patterns, the first and second terminal impellers each include blade arrangements configured to provide a centrifugal and axial fluid flow directed toward the rotor central impeller. The first and second terminal impeller blade arrangements may transition over the longitudinal axis of the rotor to define the central impeller blade arrangement, or alternatively the first and second terminal impeller blade arrangements and the central blade arrangement may be separate.


In another aspect, a rotor as described above is provided for a two-stage axial-centrifugal flow catheter pump for cavopulmonary assistance.


In yet another aspect, a cavopulmonary assistance device is provided including an axial axial-centrifugal flow catheter pump as described above. The device includes a motor operatively connected to the rotor, a cable connected to the rotor and/or the motor, and a deployable anchor for securing the cavopulmonary assistance device to a blood vessel wall. The motor may be directly connected to the rotor, or may be remotely operatively connected to the rotor such as via the cable. The deployable anchor is configured to allow fluid flow therethrough when deployed. A protective enclosure allowing fluid flow therethrough surrounds at least the rotor to prevent damage to a blood vessel wall.


These and other embodiments, aspects, advantages, and features of the present invention will be set forth in the description which follows, and in part will become apparent to those of ordinary skill in the art by reference to the following description of the invention and referenced drawings or by practice of the invention. The aspects, advantages, and features of the invention are realized and attained by means of the instrumentalities, procedures, and combinations particularly pointed out in the appended claims. Various patent and non-patent citations are discussed herein. Unless otherwise indicated, any such citations are specifically incorporated by reference in their entirety into the present disclosure.





BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings incorporated in and forming a part of the specification, illustrate several aspects of the present invention, and together with the description serve to explain the principles of the invention. In the drawings:



FIG. 1 depicts a normal human heart;



FIG. 2 depicts the heart of FIG. 1 after completion of a Fontan procedure, showing the Fontan anastomosis placing the superior and inferior vena cava in fluid communication with the pulmonary artery;



FIG. 3 depicts an embodiment of a rotor for an axial-centrifugal flow pump;



FIGS. 4
a, 4b, and 4c depict alternative embodiments of blade configurations for the impellers of the rotor of FIG. 3;



FIGS. 5
a and 5b depict embodiments of axial-centrifugal flow pumps according to the present disclosure; and



FIGS. 6
a and 6b depict placement of the axial-centrifugal flow pump of FIG. 5 at a site of a Fontan anastomosis, with FIG. 6a showing the device with an undeployed anchor and FIG. 6b showing the device with a deployed anchor to secure the device to the wall of the inferior vena cava.





DETAILED DESCRIPTION OF THE ILLUSTRATED EMBODIMENTS

In the following detailed description of the illustrated embodiments, reference is made to the accompanying drawings that form a part hereof, and in which is shown by way of illustration, specific embodiments in which the invention may be practiced. These embodiments are described in sufficient detail to enable those skilled in the art to practice the invention. Also, it is to be understood that other embodiments may be utilized and that process, reagent, software, and/or other changes may be made without departing from the scope of the present invention.


In the normal heart (see FIG. 1), there is no direct fluid communication between the superior vena cava (SVC), inferior vena cava (IVC), and the pulmonary artery (PA). As is known in the art and as summarized above, in the Fontan procedure venous blood flow is diverted from the SVC and IVC directly to the PA, bypassing the right ventricle of the heart. By the procedure, a surgically created junction (Fontan anastomosis F) is provided between the superior and inferior vena cava and the pulmonary artery to allow fluid communication between the vessels and directly into pulmonary circulation (see FIG. 2). As summarized above, this Fontan circulation is prone to failure, requiring additional intervention to reverse or ameliorate failing Fontan circulation and associated pathologies.


In one aspect, the present disclosure provides a rotor 10 (see FIG. 3) for an axial-centrifugal flow pump. The rotor 10 includes first and second terminal impellers 12, 14 and an elongated central shaft 16 supporting a central impeller 18. The first and second impellers 12, 14 are each configured to create a centrifugal and axial fluid flow when rotor 10 is rotated, specifically wherein the first and second impellers 12, 14 create axial fluid flows in opposed directions (see arrows A). In particular embodiments, the first and second impellers 12, 14 include at least one blade 20 disposed at an included angle of from about 10 to about 30 degrees relative to a longitudinal axis of the rotor 10 to provide the desired axial and centrifugal fluid flow.


The central impeller 18, on the other hand, includes at least one blade 22 disposed whereby rotation of rotor 10 creates a predominantly centrifugal fluid flow around central impeller 16 (see arrows B). In particular embodiments, the central impeller 18 includes at least one blade 22 disposed at an included angle of from about 80 to about 100 degrees relative to a longitudinal axis of the rotor 10 to provide the desired centrifugal fluid flow. In use, rotation of the rotor 10 will cause first and second impellers 12, 14 to promote a centrifugal and axial flow of fluid in the direction of central impeller 18, while central impeller 18 redirects that axial fluid flow into a primarily centrifugal fluid flow.


In the embodiment shown in FIG. 3, the blades 20, 22 are of the Archimedean screw type. In the depicted embodiment of FIG. 3, blades 20 of the first and second impellers 12, 14 transition over a longitudinal axis of the rotor 10 to define the blades 22 of the central impeller 18. However, a variety of blade configurations are contemplated for inclusion in the rotor 10 described above. As a non-limiting example, a propeller or screw type blade 20 is contemplated for use in first and second impellers 12, 14 (see FIG. 4a). Alternatively, first and second impellers 12, 14 may include a plurality of discrete blades 20 (see FIG. 4b); with the caveat that the blades 20 must be oriented such that a centrifugal and axial fluid flow is promoted as described above. As another alternative, an auger-type blade 20 may be used (see FIG. 4c). Similar arrangements are contemplated for use as blades 22 of central impeller 18, with the caveat that the blades 22 must be oriented such that a predominantly centrifugal fluid flow is promoted by the central impeller 18 as described above.


In another aspect (see FIG. 5a), the present disclosure provides an axial-centrifugal flow pump 24 incorporating the rotor 10 as described above, for use as a cavopulmonary assistance device (CPAD). The rotor 10 is provided with bearing arrangements 26, 28 at opposed ends thereof to allow rotation of rotor 10. A number of bearings are contemplated for use as bearings 26, 28, including without intending any limitation ball bearings, roller bearings, cone bearings, ball thrust bearings, roller thrust bearings, magnetic bearings, and the like.


A motor 30 is operatively connected to rotor 10 to drive rotation thereof. In the embodiment of FIG. 5, the rotor 10 is held by bearings 26 in a micro motor 30. A stator 32 is provided at the opposed end of rotor 10, to support rotation of rotor 10 in conjunction with bearing 28. In an embodiment, bearing 28 may be a cone bearing of substantially known design, supported by stator 32. However, other designs are contemplated for bearings 26, 28 as described above. A protective enclosure 34 is also provided, to prevent contact of the rotor 10 with, e.g., a blood vessel wall interior. A number of suitable enclosures 34 are contemplated, such as a cage made of wire or other suitable materials allowing blood flow therethrough to prevent fluid flow occlusion or reduction and areas of stagnant blood flow. Such devices are known in the art. An expandable or deployable anchor 36 is included at a terminus of the pump 24, whose function will be described in detail below. A cable 36 is provided at a terminus of the pump 24, one function of which is to facilitate placement of the pump 34 at a desired location in a blood vessel. In combination, cable 36 and pump 24 define a catheter pump which provides both an axial and a centrifugal fluid flow as described above, in a compact, self-contained design promoting patient mobility after placement of the pump 24.


The skilled artisan will appreciate that alternative configurations are possible and are contemplated herein. For example, rather than directly associating the motor 30 with the pump 24 as depicted in the embodiment of FIG. 5, the motor 30 may be disposed remotely from the pump 24, and operatively connected to the rotor 10 via cable 36 (see FIG. 5b). A second stator 32 and bearing 26 arrangement may be included to stabilize the end of rotor 10 connected to cable 36. In this embodiment, motor 30 may be positioned extracorporeally during use of pump 24, facilitating maintenance and/or replacement thereof in case of failure.


Deployment and use of pump 24 such as in the event of failing Fontan circulation will now be described. As summarized above, the Fontan procedure results in a surgically created junction (Fontan anastomosis) between the superior and inferior vena cava and the pulmonary artery to allow fluid communication between the vessels (see FIG. 2). To improve that failing Fontan circulation, pump 24 is inserted into, for example, the right jugular vein and therefrom into the superior vena cava and advanced using cable 36 and/or a suitable guidewire/deployment catheter or balloon dilation catheter arrangement (not shown) of known design. Advancement and proper placement of pump 24 may be monitored by any suitable imaging technology, such as X-ray fluoroscopy, radiography, intravascular ultrasound, etc., to ensure proper positioning of the pump 24.


The pump 24 is advanced until the rotor 10 bridges the Fontan anastomosis F (see FIG. 6a). As shown, first impeller 12 is positioned substantially in the superior vena cava (SVC), second impeller 14 is positioned substantially in the inferior vena cava (IVC), and central impeller 18 bridges the Fontan anastomosis F, i.e. the surgically created juncture between the SVC, IVC, right pulmonary artery (RPA), and left pulmonary artery (LPA). Once proper placement of the pump 24 is verified, the expandable or deployable anchor 36 is deployed to anchor the pump 24 to the IVC vessel wall and prevent undesired movement of the pump 24 (see FIG. 6b). Typically, an anchor 36 is used which allows fluid flow therethrough after deployment, to prevent occlusion or reduction of blood flow through the blood vessel and to prevent areas of stagnant blood flow after the anchor 36 is deployed.


On rotation of rotor 10, as described above first and second impellers 12, 14 created a centrifugal and axial fluid flow of blood in the direction of central impeller 18 (see arrows A). In turn, as rotor 10 rotates, central impeller 18 creates a predominantly centrifugal fluid flow of blood substantially at the location of the Fontan anastomosis, accelerating blood spinning in this region of the superior and inferior vena cava and creating a high pressure zone in the region of the blood vessel extending between the first and second impellers 12, 14 (see shaded area Z). This provides a delivery of blood at substantially right angles into the RPA and LPA (arrows C). By the pump 24 of the present disclosure, blood flow is promoted from the superior vena cava/inferior vena cava into the pulmonary circulation, eliminating the increased central venous pressure required to promote this type of blood flow as is typically associated with Fontan procedure.


A number of advantages are realized by the rotor 10/axial-centrifugal flow pump 24 design of the present disclosure. For example, separation of the first and second impellers 12, 14 by elongated shaft 16 allows for some movement of the rotor 10/pump 24 within the superior vena cava and inferior vena cava after placement and deployment of anchor 36 without affecting the performance of pump 24 and without disrupting the blood flow created by pump 24 as described above. This eliminates the need for unduly precise placement at the site of a Fontan anastomosis associated with prior art pumps to promote the desired blood flow into pulmonary circulation, and also obviates the loss of performance of such prior art pumps if the pump is at all displaced during use. In turn, a compact, effective, and efficient pump 24 design is provided which, by its size and flexibility in placement, allows patient ambulation after the pump 24 is placed.


One of ordinary skill in the art will recognize that additional embodiments of the invention are also possible without departing from the teachings herein. This detailed description, and particularly the specific details of the exemplary embodiments, is given primarily for clarity of understanding, and no unnecessary limitations are to be imported, for modifications will become obvious to those skilled in the art upon reading this disclosure and may be made without departing from the spirit or scope of the invention. Relatively apparent modifications, of course, include combining the various features of one or more figures or examples with the features of one or more of other figures or examples.

Claims
  • 1. An axial-centrifugal flow catheter pump for cavopulmonary assistance, comprising: a rotor providing both an axial fluid flow and a centrifugal fluid flow; anda motor operatively connected to the rotor;the rotor including a first terminal impeller configured to provide a centrifugal and axial fluid flow in a first direction, a second terminal impeller configured to provide a centrifugal and axial fluid flow in a second direction opposite to the first direction, and a central impeller configured to provide a predominantly centrifugal fluid flow.
  • 2. The axial-centrifugal flow catheter pump of claim 1, wherein the first and second terminal impellers each include blade arrangements configured to provide a centrifugal and axial fluid flow directed toward the rotor central impeller.
  • 3. The axial-centrifugal flow catheter pump of claim 2, wherein the first and second terminal impeller blade arrangements include at least one blade oriented at an included angle of from 10 to 30 degrees relative to a longitudinal axis of the rotor.
  • 4. The axial-centrifugal flow catheter pump of claim 1, wherein the central impeller includes a blade arrangement having at least one blade oriented at an included angle of from 80 to 100 degrees relative to a longitudinal axis of the rotor.
  • 5. The axial-centrifugal flow catheter pump of claim 4, wherein the first and second terminal impeller blade arrangements transition over the longitudinal axis of the rotor to define the central impeller blade arrangement.
  • 6. A rotor for a two-stage axial-centrifugal flow catheter pump for cavopulmonary assistance, comprising: a first terminal impeller configured to provide a centrifugal and axial fluid flow in a first direction;a second terminal impeller configured to provide a centrifugal and axial fluid flow in a second direction opposite to the first direction; anda central impeller configured to provide a predominantly centrifugal fluid flow.
  • 7. The rotor of claim 6, wherein the first and second terminal impellers each include blade arrangements configured to provide a centrifugal and axial fluid flow directed toward the rotor central impeller.
  • 8. The rotor of claim 7, wherein the first and second terminal impeller blade arrangements include at least one blade oriented at an included angle of from 10 to 30 degrees relative to a longitudinal axis of the rotor.
  • 9. The rotor of claim 6, wherein the central impeller includes a blade arrangement configured to provide a predominantly centrifugal fluid flow and having at least one blade oriented at an included angle of from 80 to 100 degrees relative to a longitudinal axis of the rotor.
  • 10. The rotor of claim 9, wherein the first and second terminal impeller blade arrangements transition over the longitudinal axis of the rotor to define the central impeller blade arrangement.
  • 11. A cavopulmonary assistance device, comprising: an axial-centrifugal flow catheter pump comprising a rotor providing both an axial fluid flow and a centrifugal fluid flow and a motor operatively connected to the rotor;a cable connected to the rotor and/or the motor; anda deployable anchor for securing the cavopulmonary assistance device to a blood vessel wall;the rotor including a first terminal impeller configured to provide a centrifugal and axial fluid flow in a first direction, a second terminal impeller configured to provide a centrifugal and axial fluid flow in a second direction opposite to the first direction, and a central impeller configured to provide a predominantly centrifugal fluid flow.
  • 12. The cavopulmonary assistance device of claim 11, wherein the first and second terminal impellers each include blade arrangements configured to provide a centrifugal and axial fluid flow directed toward the rotor central impeller.
  • 13. The cavopulmonary assistance device of claim 12, wherein the first and second terminal impeller blade arrangements include at least one blade oriented at an included angle of from 10 to 30 degrees relative to a longitudinal axis of the rotor.
  • 14. The cavopulmonary assistance device of claim 11, wherein the central impeller includes a blade arrangement having at least one blade oriented at an included angle of from 80 to 100 degrees relative to a longitudinal axis of the rotor.
  • 15. The cavopulmonary assistance device of claim 14, wherein the first and second terminal impeller blade arrangements transition over the longitudinal axis of the rotor to define the central impeller blade arrangement.
  • 16. The cavopulmonary assistance device of claim 11, wherein the motor is directly connected to the rotor.
  • 17. The cavopulmonary assistance device of claim 11, wherein the motor is remotely operatively connected to the rotor.
  • 18. The cavopulmonary assistance device of claim 11, wherein the deployable anchor is configured to allow passage of fluid therethrough when deployed.
  • 19. The cavopulmonary assistance device of claim 11, further including a bearing arrangement disposed at opposed ends of the rotor and a stator disposed at an end of the rotor opposed to the motor.
  • 20. The cavopulmonary assistance device of claim 11, further including a protective enclosure surrounding at least the rotor, the protective enclosure being configured to allow fluid flow therethrough.
US Referenced Citations (137)
Number Name Date Kind
973868 Kneuper Oct 1910 A
2273558 Burgess Feb 1942 A
2474665 Guarino Jun 1949 A
2742158 Schuller Apr 1956 A
3103928 Broman Sep 1963 A
3183908 Collins et al. May 1965 A
3410263 McGinnis Nov 1968 A
3429443 Howard Feb 1969 A
3768977 Brumfield et al. Oct 1973 A
3855995 Bentley Dec 1974 A
3856475 Marx Dec 1974 A
3898045 Bowley Aug 1975 A
3934982 Arp Jan 1976 A
3935110 Schmid et al. Jan 1976 A
3960657 Bowley Jun 1976 A
4017279 Bowley Apr 1977 A
4094792 Bentley Jun 1978 A
4098275 Consalvo Jul 1978 A
4134402 Mahurkar Jan 1979 A
4188360 Kurata Feb 1980 A
4196075 Bentley Apr 1980 A
4205042 Giurtino et al. May 1980 A
4268476 Raible May 1981 A
4297318 Raible Oct 1981 A
4368118 Siposs Jan 1983 A
4372914 Raible Feb 1983 A
4374088 Stenberg et al. Feb 1983 A
4533516 Johnsson et al. Aug 1985 A
4568253 Wood Feb 1986 A
4573883 Noon et al. Mar 1986 A
4612126 Alt et al. Sep 1986 A
4623518 Raible Nov 1986 A
4698207 Bringham et al. Oct 1987 A
4770652 Mahurkar Sep 1988 A
4808155 Mahurkar Feb 1989 A
4846152 Wampler et al. Jul 1989 A
4874581 Sutherland et al. Oct 1989 A
4906229 Wampler Mar 1990 A
4908014 Kroyer Mar 1990 A
4915837 Verity Apr 1990 A
4925377 Inacio et al. May 1990 A
4975247 Badolato et al. Dec 1990 A
5034188 Nakanishi et al. Jul 1991 A
RE33932 Fukasawa et al. May 1992 E
5116308 Hagiwara May 1992 A
5120501 Mathewson et al. Jun 1992 A
5139741 Hagiwara Aug 1992 A
5158533 Strauss et al. Oct 1992 A
5188732 De Niel et al. Feb 1993 A
5197951 Mahurkar Mar 1993 A
5217689 Raible Jun 1993 A
5221255 Mahurkar et al. Jun 1993 A
5225161 Mathewson et al. Jul 1993 A
5236665 Mathewson et al. Aug 1993 A
5270004 Cosentino et al. Dec 1993 A
5270005 Raible Dec 1993 A
5282783 Lindsay Feb 1994 A
5316724 Mathewson et al. May 1994 A
5338512 Mathewson et al. Aug 1994 A
5354277 Guzman et al. Oct 1994 A
5358689 Jones et al. Oct 1994 A
5374245 Mahurkar Dec 1994 A
5395525 Takano et al. Mar 1995 A
5421405 Goodin et al. Jun 1995 A
5476444 Keeling et al. Dec 1995 A
5507629 Jarvik Apr 1996 A
5578077 Kassatly Nov 1996 A
5718871 Elgas Feb 1998 A
5725357 Nakazeki et al. Mar 1998 A
5762868 Leonard Jun 1998 A
5762875 Gremel et al. Jun 1998 A
5770149 Raible Jun 1998 A
5787729 Wijaya Aug 1998 A
5788287 Gremel Aug 1998 A
5817279 Eilers et al. Oct 1998 A
5823987 Elgas et al. Oct 1998 A
5851174 Jarvik et al. Dec 1998 A
5858233 Elgas et al. Jan 1999 A
5906741 Elgas et al. May 1999 A
5922202 Elgas et al. Jul 1999 A
5958255 Hobrecht et al. Sep 1999 A
5964694 Siess et al. Oct 1999 A
6017493 Cambron et al. Jan 2000 A
6048363 Nagyszalanczy et al. Apr 2000 A
6220832 Schob Apr 2001 B1
6224829 Piplani et al. May 2001 B1
6247892 Kazatchkov et al. Jun 2001 B1
6336911 Westerbeck Jan 2002 B1
6368557 Piplani et al. Apr 2002 B1
6379618 Piplani et al. Apr 2002 B1
6395226 Plunkett May 2002 B1
6406452 Westerbeck Jun 2002 B1
6413233 Sites et al. Jul 2002 B1
6428747 Dueri et al. Aug 2002 B1
6454999 Farhangnia et al. Sep 2002 B1
6497841 Plotkin et al. Dec 2002 B1
6503450 Afzal et al. Jan 2003 B1
6508983 McBurney et al. Jan 2003 B1
6527699 Goldowsky Mar 2003 B1
6572821 Knott Jun 2003 B2
6579496 Fausset et al. Jun 2003 B1
6613008 Aboul-Hosn et al. Sep 2003 B2
6630107 Merce Vives Oct 2003 B1
6644320 Groth et al. Nov 2003 B2
6669661 Yee Dec 2003 B1
6682698 Chambers et al. Jan 2004 B2
6689315 Linker et al. Feb 2004 B2
6716157 Goldowsky Apr 2004 B2
6716188 Noda et al. Apr 2004 B2
6723283 Ghelli et al. Apr 2004 B2
6726653 Noda et al. Apr 2004 B2
6730267 Stringer et al. May 2004 B2
6746416 Hubbard et al. Jun 2004 B2
6884360 Chang Apr 2005 B2
6908446 Yokoyama et al. Jun 2005 B2
6960322 Stringer et al. Nov 2005 B2
7022099 Litzie et al. Apr 2006 B2
7022284 Brian et al. Apr 2006 B2
7135008 O'Mahony et al. Nov 2006 B2
7238320 Ghelli et al. Jul 2007 B2
7541000 Stringer et al. Jun 2009 B2
7704054 Horvath et al. Apr 2010 B2
7785247 Tatum et al. Aug 2010 B2
8152443 Pemberton Apr 2012 B1
20040226868 Shoji et al. Nov 2004 A1
20060009728 Litzie et al. Jan 2006 A1
20060177343 Brian, III et al. Aug 2006 A1
20060253194 Dial Nov 2006 A1
20070073393 Kung et al. Mar 2007 A1
20070217948 Ghelli et al. Sep 2007 A1
20070249888 Wu et al. Oct 2007 A1
20080199357 Gellman et al. Aug 2008 A1
20080234623 Strauss et al. Sep 2008 A1
20100168848 Horvath et al. Jul 2010 A1
20110257462 Rodefeld et al. Oct 2011 A1
20120095280 Timms Apr 2012 A1
20130094997 Wang et al. Apr 2013 A1